Ramirez Alexies, Pacchia Christina F, Sanders Natalie A, Wasmund Stephen L, Hamdan Mohamed H
Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
J Interv Card Electrophysiol. 2012 Dec;35(3):285-91; discussion 291. doi: 10.1007/s10840-012-9716-z. Epub 2012 Aug 11.
The effects of radio-frequency ablation (RFA) on blood pressure (BP) regulation in patients with atrial fibrillation (AF) and hypertension remain unknown. We hypothesized that patients with successful ablation had a lower BP and/or lesser utilization of antihypertensive drug therapy during follow-up when compared to patients with failed ablation.
This was a retrospective evaluation of patients with AF and hypertension treated with ablation at the University of Utah between July 2006 and June 2010. BP and use of antihypertensive medications were assessed at baseline and 1 year follow-up. A total of 167 patients were identified. Eight patients were excluded due to the need for AAD therapy beyond the blanking period thus leaving 80 patients in the success group and 79 patients in the failure group. The mean BP and HR at baseline were not significant between the groups. In the success group, the mean systolic BP decreased from a baseline value of 129 ± 17 to 125 ± 14 mmHg at 1 year (p = 0.075). In contrast, in the failure group, the mean systolic BP increased from a baseline value of 124 ± 16 to 127 ± 14 mmHg at 1 year (p = 0.176). Between-group comparison revealed a p value of 0.026. Minimal changes in diastolic BP were noted in both groups. No significant changes in antihypertensive therapy were noted.
We have shown that successful catheter ablation in patients with AF and hypertension is associated with a decrease in systolic BP when compared to an increase in patients with failed ablation. Our findings suggest that restoring sinus rhythm could have an antihypertensive effect in patients with AF and hypertension.
射频消融(RFA)对心房颤动(AF)合并高血压患者血压(BP)调节的影响尚不清楚。我们假设,与消融失败的患者相比,消融成功的患者在随访期间血压较低和/或降压药物治疗的使用较少。
这是一项对2006年7月至2010年6月在犹他大学接受消融治疗的AF合并高血压患者的回顾性评估。在基线和随访1年时评估血压和降压药物的使用情况。共确定了167例患者。8例患者因在空白期后需要抗心律失常药物治疗而被排除,因此成功组有80例患者,失败组有79例患者。两组之间基线时的平均血压和心率无显著差异。在成功组中,平均收缩压从基线值129±17 mmHg降至1年时的125±14 mmHg(p = 0.075)。相比之下,在失败组中,平均收缩压从基线值124±16 mmHg升至1年时的127±14 mmHg(p = 0.176)。组间比较显示p值为0.026。两组舒张压变化均极小。未观察到降压治疗有显著变化。
我们已经表明,与消融失败的患者血压升高相比,AF合并高血压患者成功的导管消融与收缩压降低有关。我们的研究结果表明,恢复窦性心律可能对AF合并高血压患者有降压作用。